Sotalol hydrochloride approved for treatment of ventricular arrhythmias, maintenance of normal sinus rhythm

25.10.20141536
Arbor Pharmaceuticals announced that the FDA has approved a new drug application for sotalol hydrochloride oral solution for the treatment of documented life-threatening ventricular arrhythmias and the maintenance of normal sinus rhythm in patients with a history of highly symptomatic atrial fibrillation or flutter.

Use of Coumarin Anticoagulants and Cerebral Microbleeds in the General Population

24.10.20141776
Does the use of warfarin relate to a higher prevalence and incidence of cerebral microbleeds?

Electrophysiologic Substrate in Congenital Long QT Syndrome: Noninvasive Mapping with Electrocardiographic Imaging (ECGI)

22.10.20141382
Congenital Long QT syndrome (LQTS) is an arrhythmogenic disorder that causes syncope and sudden death.

Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction

21.10.20141600
What is the potential role of Subtance P (SP) in acute myocardial infarction (AMI) and its association with major adverse cardiac events (MACE) such as death, heart failure (HF), or reinfarction?

Flow Reserve: Linking Physiologic Severity to Clinical Outcomes

20.10.20141488
What is the relationship between fractional flow reserve (FFR) numeric value and prognosis?

Ученые пересмотрели и сравнили сердечно-сосудистый риск в 17 странах с разным уровнем доходов

17.10.20141701
More than 80% of deaths from cardiovascular disease are estimated to occur in low-income and middle-income countries, but the reasons are unknown.

Genetic test identified risk for AF, ischemic stroke

16.10.20141500
A genetic risk score derived from 12 genetic variants associated with increased risk for atrial fibrillation improved the identification of individuals with increased risk for AF and ischemic stroke, according to study data.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.